A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery

A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery

Year of publication

2023

Authors

Benjakul, Sopisa; Anthi, Aina Karen; Kolderup, Anette; Vaysburd, Marina; Lode, Heidrun Elisabeth; Mallery, Donna; Fossum, Even; Vikse, Elisabeth Lea; Albecka, Anna; Ianevski, Aleksandr; Kainov, Denis; Karlsen, Karine Flem; Sakya, Siri Aastedatter; Nyquist-Andersen, Mari; Gjolberg, Torleif Tollefsrud; Moe, Morten C.; Bjoras, Magnar; Sandlie, Inger; James, Leo C.; Andersen, Jan Terje
Show more

Organizations and authors

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Parent publication name

PNAS nexus

Volume

2

Issue

12

​Publication forum

90972

​Publication forum level

1

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Fully open publication channel

Self-archived

Yes

License of the self-archived publication

CC BY

Other information

Fields of science

Biomedicine

Publication country

United Kingdom

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

No

DOI

10.1093/pnasnexus/pgad403

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes

A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery - Research.fi